Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Neurology|February 10, 2015
Measuring quality of life in muscular dystrophyCarla M Bann, Richard T Abresch, Barbara Biesecker, et al.
Neurology|November 20, 2015
Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2)Chad Heatwole, Nicholas Johnson, Rita Bode, et al.
Pharmacotherapy|May 14, 2025
Effect of creatine monohydrate on motor function in children with facioscapulohumeral muscular dystrophy: A multicenter, randomized, double-blind placebo-controlled crossover trialIan R Woodcock, Katy de Valle, Anita Cairns, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 16, 2023
The amyotrophic lateral sclerosis-health index (ALS-HI): development and evaluation of a novel outcome measureAnika Varma, Jennifer Weinstein, Jamison Seabury, et al.
Eclinicalmedicine|December 19, 2022
Patient reported impact of symptoms in amyotrophic lateral sclerosis (PRISM-ALS): A national, cross-sectional studyChristine Zizzi, Jamison Seabury, Spencer Rosero, et al.
Neurology|November 28, 2022
Patient-Reported Impact of Symptoms in Friedreich AtaxiaJamison Seabury, Danae Alexandrou, Nuran Dilek, et al.
Neurology. Clinical Practice|August 30, 2023
Friedreich's Ataxia-Health Index: Development and Validation of a Novel Disease-Specific Patient-Reported Outcome MeasureJamison Seabury, Spencer Rosero, Anika Varma, et al.
Muscle & Nerve|June 6, 2015
Myotonic dystrophy health index: Correlations with clinical tests and patient functionChad Heatwole, Rita Bode, Nicholas E Johnson, et al.
Neurology|October 13, 2020
Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled TrialChad Heatwole, Elizabeth Luebbe, Spencer Rosero, et al.
Dysphagia|June 8, 2023
Assessing Prevalence and Characteristics of Oro-bulbar Involvement in Children and Adults with SMA Type 2 and 3 Using a Multimodal ApproachFederica Trucco, Francesca Salmin, Andrea Lizio, et al.
Pageof 7